Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain 7Cancer Pain 4Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Postoperative Complications 1Ovarian Neoplasms 1Neuralgia 1Neoplasms 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Follicular 1Intraoperative Complications 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Emergencies 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Acute Pain 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Hydromorphone × Clear all
NCT02461056 2015-06-03

Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain

Samsung Medical Center

Phase NA Completed
90 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡